"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani: The idea that early use of parp inhibitors would be beneficial, while late use would be harmful, lacks plausibility and a reasonable explanation.
Yüksel Ürün Highlights ML-integrated Biomarker Insights from CheckMate 9ER
Ashwini Gupta: Research method workshop: From writing proposal to getting manuscript published
Targeting CCR7-PI3Ky overcomes resistance to tyrosine kinase inhibitors AKL-rearranged lymphoma - Marco Campisi
Maria (Masha) Babak: FDA grants accelerated approval to Braftovi for the treatment of metastatic colorectal cancer
Michael Wang: CDK9 is a promising target in MCL
